(Q45639061)

14 December 2017

title

Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens (English)

1 reference

Infectious bursal disease virus

14 December 2017

1 reference

object named as

infectious bursal disease virus

1 reference

Christophe Chevalier

2

0 references

Achille François

series ordinal

1

object named as

Achille Francois

1 reference

14 December 2017

4

Nicolas Eterradossi

1 reference

14 December 2017

5

Didier Toquin

1 reference

14 December 2017

6

Gaëlle Rivallan

1 reference

14 December 2017

Bernard Delmas

3

1 reference

14 December 2017

Patrick Langlois

series ordinal

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 December 2017

1 reference

14 December 2017

volume

22

1 reference

14 December 2017

issue

17-18

1 reference

14 December 2017

page(s)

2351-2360

1 reference

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

An adenovirus recombinant expressing the spike glycoprotein of porcine respiratory coronavirus is immunogenic in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Delivery of avian cytokines by adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Construction of avian adenovirus CELO recombinants in cosmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

DNA-mediated vaccination against infectious bursal disease in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

VP5 of infectious bursal disease virus is not essential for viral replication in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Generation of a mutant infectious bursal disease virus that does not cause bursal lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.10.039

1 reference

14 December 2017

1 reference